Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C065250 |
4-hydroxy-equilenin |
4-hydroxy-equilenin results in increased expression of RPL23A mRNA | increases expression | 15135645
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of RPL23A mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RPL23A mRNA | affects expression | 16483693
|
D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of RPL23A mRNA | affects expression | 17602206
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL23A mRNA | affects cotreatment|increases expression | 17183730
|
D008727 |
Methotrexate |
RPL23A protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D017239 |
Paclitaxel |
RPL23A mRNA results in decreased susceptibility to Paclitaxel | decreases response to substance | 16322897
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RPL23A mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of RPL23A mRNA | decreases expression | 19465110
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL23A mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
16.05 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
16.05 | 14514962 15322242 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
16.05 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.13 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.84 | 18287403 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.66 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.55 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.16 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.74 | 17497229 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.14 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.86 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.86 | 15238991 18940202 16609825 17688650 17507914 17157402 18775368 18396377 19460635 18316065 20603192 19232924 18558336 18177632 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.17 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.25 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.43 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.43 | 8888407 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.79 | 15867366 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.04 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.04 | 16244791 15136595 16273361 16115903 18223236 11325840 18234424 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.04 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
3.18 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
3.18 | 16313753 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 18850075 16120746 18670907 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.69 | 10977129 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.77 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 8697196 12621046 15340226 15668235 16354765 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
2.44 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.98 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.98 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.98 | 17688650 8888407 16575769 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.43 | 19747007 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.36 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.45 | 16393943 14550746 16081117 11834606 2444490 19739265 16485898 11461765 12958197 18071297 17562736 10663392 19923254 11287661 15619225 19416960 19164858 16227642 11739529 12153990 11743745 14986274 16109766 12540782 12594235 11529661 19370779 12705907 10774834 10915739 19085960 17522070 18713872 11421492 16177239 15968718 19420014 14725611 12392966 17906064 16781746 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.45 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.45 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.42 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.27 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.58 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.41 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.23 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.03 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.77 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.56 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.35 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
2.93 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.50 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.20 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.37 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.21 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.99 | 16983495 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.41 | 16518429 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.43 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.15 | 16120746 15340226 12621046 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 18606429 16354765 15340226 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.86 | 16870215 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.88 | 16612254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.95 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.30 | 12587719 15629191 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.32 | 9562676 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 16294345 17596541 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
5.04 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.80 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.67 | 19784758 12587719 19014921 16610002 19460945 11587558 12969438 16611625 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.43 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
4.79 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.22 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
12.55 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
12.55 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.09 | 17352296 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
4.26 | 14749477 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
2.61 | 16342250 12025231 12040289 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.83 | 19513568 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.33 | 18765137 18803445 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.57 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.83 | 14749477 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.23 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.26 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
3.32 | 15867366 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.45 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.25 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.04 | 18514411 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.26 | 15867366 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
3.04 | 11161223 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.56 | 16870215 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.43 | 11118676 11896295 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
10.43 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
3.82 | 17136230 17172428 16729912 16356831 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.86 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.49 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.97 | 17352296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.40 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.87 | 14763951 15475178 16876388 11044598 1511512 3137016 11738929 17978042 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.13 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.94 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.86 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.44 | 18506536 18396642 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.27 | 9562676 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
5.10 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.55 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.81 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.90 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.20 | 10982225 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |